Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Dysexecutive Alzheimer’s Disease with Lewy Body Disease Co-Pathology
Coburn, Ryan P , Graff‐Radford, Jonathan , Reichard, R. Ross , Ramanan, Vijay K. , Ramanan, Vijay K , Botha, Hugo , Jones, David T.

Mayo Clinic

Current Alzheimer Research | March 9, 2022 | Volume: 19 | Issue: 4 | Pages: 330-333

10.2174/1567205019666220308152219 | PMID 35260054 Get It

Background: Alzheimer’s disease can present atypically as a progressive dysexecutive syndrome (dAD), an entity that preferentially affects younger individuals and is frequently misdiagnosed, highlighting the imperative for additional research. Objective: The objective of this study is to characterize the clinical, antemortem neuroimaging, and postmortem neuropathologic features of two cases of young-onset dAD who displayed evidence of Lewy body disease (LBD) co-pathology at autopsy. Methods: Clinical histories, antemortem MRI and PET imaging, and postmortem neuropathologic data were reviewed for each patient. Case Descriptions/Results: Canonical features of dAD were observed in both cases, including progressive and predominant impairment in tasks related to working memory and cognitive flexibility, a lack of major behavioral/personality changes, and evidence of abnormal amyloid and tau deposition by antemortem amyloid and tau PET and postmortem neuropathology. Relative sparing of hippocampal involvement was observed in both individuals, in keeping with many cases of clinically atypical AD. One of the patients developed subtle parkinsonian signs as well as paranoia and irritability in the years prior to passing. In both cases, transitional (brainstem and limbic) LBD co-pathology was observed at autopsy. Discussion: Although LBD co-pathology is not uncommon in AD overall, the presence of LBD pathology in these young-onset cases of dAD (including a case with apparent symptomatic correlate) warrants further investigation for broader frequency and underlying pathophysiology. Conclusion: A better understanding of which specific young-onset AD phenotypes are associated with LBD co-pathology would have important implications for counseling, treatment, clinical trial enrollment, and knowledge on disease mechanisms.
Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
Chen, Qin , Przybelski, Scott A. , Senjem, Matthew L. , Lesnick, Timothy G. , Graff‐Radford, Jonathan , Savica, Rodolfo , Fields, Julie A. , Jain, Manoj , Graff‐Radford, Neill R., Ferman, Tanis J. , Kremers, Walter K. , Jack, Clifford R. , Petersen, Ronald C. , Lowe, Val J. , Kantarci, Kejal , Graff-Radford, Jonathan , Savica, Rodolfo , Kantarci, Kejal , Jack, Clifford R , Senjem, Matthew L , Ferman, Tanis J , Kremers, Walter K , Schwarz, Christopher G. , Botha, Hugo , Knopman, David S. , Jones, David T. , Graff‐Radford, Neill R. , Boeve, Bradley F.

Mayo Clinic

Movement Disorders | March 9, 2022 | Volume: 37 | Issue: 6 | Pages: 1256-1264

10.1002/mds.28973 | PMID 35261094 Get It

ABSTRACT Background and Objective Patients with dementia with Lewy bodies (DLB) may have overlapping Alzheimer's disease pathology. We investigated the longitudinal rate of tau accumulation and its association with neurodegeneration and clinical disease progression in DLB. Methods Consecutive patients with probable DLB (n = 22) from the Mayo Clinic Alzheimer's Disease Research Center and age‐matched and sex‐matched cognitively unimpaired controls (CU; n = 22) with serial magnetic resonance imaging and flortaucipir positron emission tomography scans within an average of 1.6 years were included. Regional annualized rates of flortaucipir uptake standardized uptake value ratios (SUVr) were calculated. Regional annualized rates of cortical volume change were measured with the Tensor Based Morphometry–Syn algorithm. Results The annual increase of flortaucipir SUVr was greater in the middle and superior occipital, fusiform, and inferior parietal cortices in DLB (mean: 0.017, 0.019, 0.019, and 0.015, respectively) compared with the CU (mean: −0.006, −0.009, −0.003, and − 0.005, respectively; P < 0.05). In patients with DLB (but not the CU), a longitudinal increase in flortaucipir SUVr was associated with longitudinal cortical atrophy rates in the lateral occipital and inferior temporoparietal cortices, hippocampus, and the temporal pole as well as a concurrent decline on Mini‐Mental State Examination and Clinical Dementia Rating–Sum of Boxes in the lateral occipital and the fusiform cortices. Conclusions Tau accumulation was faster in DLB compared with the CU, with increased accumulation rates in the lateral occipital and temporoparietal cortices. These increased rates of tau accumulation were associated with neurodegeneration and faster disease progression in DLB. Tau may be a potential treatment target in a subset of patients with DLB. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society
Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Far Lateral Approach
Graffeo, Christopher S. , Perry, Avital , Leonel, Luciano, Driscoll, Colin L. W., Link, Michael J., Peris‐Celda, Maria , Carlstrom, Lucas P. , Morris, Jonathan M. , Link, Michael J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 4, 2022 | Volume: 83 | Issue: S 01 | Pages: S1-S270

10.1055/s-0042-1743856 Get It

Stereoscopic Photogrammetry: Technical Note on the Future of Skull Base Education
Leonel, Luciano, Alexander, Yohan A., Link, Michael J. , Peris‐Celda, Maria , Pinheiro‐Neto, Carlos , Morris, Jonathan M.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | March 4, 2022 | Volume: 83 | Issue: S 01 | Pages: S1-S270

10.1055/s-0042-1743648 Get It

Using advanced racial and ethnic identity demographics to improve surveillance of work‐related conditions in an occupational clinic setting
Montoya‐Barthelemy, Andre , Leniek, Karyn , Bannister, Emily L., Rushing, Marcus D. , Abrar, Fozia A., Baumann, Tobias E., Manly, Madeleine, Wilhelm, Jonathan , Niece, Ashley D., Riester, Scott M. , Sellman, Jonathan, Anderson, Paul J., Bovard, Ralph , Pronk, Nicolas P., McKinney, Zeke J. , Montoya-Barthelemy, Andre G , Riester, Scott , Kim, Hyun , McKinney, Zeke J , Wilhelm, Jonathan, Desai, Jay

Mayo Clinic

American Journal of Industrial Medicine | March 2, 2022 | Volume: 65 | Issue: 5 | Pages: 357-370

10.1002/ajim.23332 | PMID 35235683 Get It

AbstractBackgroundAlthough racial and ethnic identities are associated with a multitude of disparate medical outcomes, surveillance of these subpopulations in the occupational clinic setting could benefit enormously from a more detailed and nuanced recognition of racial and ethnic identity.MethodsThe research group designed a brief questionnaire to capture several dimensions of this identity and collected data from patients seen for work‐related conditions in four occupational medicine clinics from May 2019 through March 2020. Responses were used to calculate the sensitivity and specificity of extant racial/ethnic identity data within our electronic health records system, and were compared to participants' self‐reported industry and occupation, coded according to North American Industry Classification System and Standard Occupational Classification System listings.ResultsOur questionnaire permitted collection of data that defined our patients' specific racial/ethnic identity with far greater detail, identified patients with multiple ethnic identities, and elicited their preferred language. Response rate was excellent (94.2%, n = 773). Non‐White participants frequently selected a racial/ethnic subcategory (78.1%–92.2%). Using our race/ethnicity data as a referent, the electronic health record (EHR) had a high specificity (>87.1%), widely variable sensitivity (11.8%–82.2%), and poorer response rates (75.1% for race, 82.5% for ethnicity, as compared to 93.8% with our questionnaire). Additional analyses revealed some industries and occupations disproportionately populated by patients of particular racial/ethnic identities.ConclusionsOur project demonstrates the usefulness of a questionnaire which more effectively identifies racial/ethnic subpopulations in an occupational medicine clinic, permitting far more detailed characterization of their occupations, industries, and diagnoses.
Aneurysmal bone cyst on top of fibro-osseous lesion of the ethmoid sinus with orbital and intracranial extension in a child
Elsayed, Ayman A., Mohamed, Rawia Mubarak , Devine, J.C. , ElBadawey, Mohamed Reda, Abdelsamad, H. S. S., Sajid, Sameeha, Mansour, Zeenah Ryad, Elsayed, Ayman Ahmed , Mohamed, Rawia Mubarak Hamad, Devine, John Charles, Wasserberg, Jonathan, Wasserberg, Jonathan

Mayo Clinic

BJR|case reports | March 2, 2022 | Volume: 8 | Issue: 3 | Pages: No page available

10.1259/bjrcr.20210246 | PMID 36101731 Get It

Objective Aneurysmal bone cysts (ABCs) rarely involve the cranium. We report a case arising in the ethmoid sinus with orbital and intracranial invasion. Imaging suggested an associated fibro-osseous lesion. The lesion was completely resected. Histology confirmed the imaging diagnosis of ABC on top of an ossifying fibroma. A multidisciplinary approach is essential for optimal surgical outcomes. Methods We report a case of an 8-year-old boy with a 5 week history of painless, increasing prominence of the left eye. Clinical examination revealed non-pulsatile left proptosis. Visual acuity and ocular movements were normal. CT and MRI scans of the maxillofacial regions showed a large space-occupying lesion involving the left ethmoid air cells with left orbital and left inferior frontal intracranial extension. Multiple fluid levels with blood products were seen. Areas of the bony component of the lesion showed ground-glass density on CT. Imaging was consistent with an ABC with an underlying fibro-osseous lesion; probably fibrous dysplasia which was confirmed after surgical removal of the lesion. A multidisciplinary team of maxillofacial, neurosusugery and ENT surgeons performed the surgery. Results ABC arising from an osseous fibroma of the skull is rare. Total resection can be achieved with a multidisciplinary surgical approach. Post-operative histology confirmed by the imaging findings.
RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma
Mladek, Ann C. , Yan, Huihuang , Tian, Shulan , Decker, Paul A. , Hu, Zeng, Connors, Margaret A. , Carlson, Brett L. , Wilson, Jonathan E. , Bommi‐Reddy, Archana, Conery, Andy, Eckel‐Passow, Jeanette E. , Kitange, Gaspar J. , Burgenske, Danielle M. , Bakken, Katrina, Sarkaria, Jann N , Mladek, Ann C , Decker, Paul A. , Bakken, Katrina K. , He, Lihong , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | February 28, 2022 | Volume: 24 | Issue: 8 | Pages: 1261-1272

10.1093/neuonc/noac051 | PMID 35231103 Get It

Abstract Background RBBP4 activates transcription by histone acetylation, but the partner histone acetyltransferases are unknown. Thus, we investigated the hypothesis that RBBP4 interacts with p300 in a complex in glioblastoma (GBM). Methods shRNA silencing of RBBP4 or p300 and RNAseq was used to identify genes co-regulated by RBBP4 and p300 in GBM43 patient-derived xenograft (PDX). RBBP4/p300 complex was demonstrated using proximity ligation assay (PLA) and ChIPseq delineated histone H3 acetylation and RBBP4/p300 complex binding in promoters/enhancers. Temozolomide (TMZ)-induced DNA double strand breaks (DSBs) were evaluated by γ-H2AX and proliferation by CyQuant and live cell monitoring assays. In vivo efficacy was based on survival of mice with orthotopic tumors. Results shRBBP4 and shp300 downregulated 4768 genes among which 1485 (31%) were commonly downregulated by both shRNAs, while upregulated genes were 2484, including 863 (35%) common genes. The pro-survival genes were the top-ranked among the downregulated genes, including C-MYC. RBBP4/p300 complex was demonstrated in the nucleus, and shRBBP4 or shp300 significantly sensitized GBM cells to TMZ compared to the control shNT in vitro (P &lt; .05). Moreover, TMZ significantly prolonged the survival of mice bearing GBM22-shRBBP4 orthotopic tumors compared with control shNT tumors (median shNT survival 52 days vs. median shRBBP4 319 days; P = .001). CREB-binding protein (CBP)/p300 inhibitor CPI-1612 suppressed H3K27Ac and RBBP4/p300 complex target proteins, including C-MYC, and synergistically sensitized TMZ in vitro. Pharmacodynamic evaluation confirmed brain penetration by CPI-1612 supporting further investigation to evaluate efficacy to sensitize TMZ. Conclusions RBBP4/p300 complex is present in GBM cells and is a potential therapeutic target.
Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
Shir, Dror , Graff‐Radford, Jonathan, Hofrenning, Ekaterina I. , Lesnick, Timothy G. , Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Jack, Clifford R. , Vemuri, Prashanthi , Campbell, Michelle R. , Stricker, Nikki H. , Jack, Clifford R , Vemuri, Prashanthi , Shir, Dror , Graff‐Radford, Jonathan , Knopman, David S. , Algeciras‐Schimnich, Alicia , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | February 28, 2022 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/dad2.12291 | PMID 35252538 Get It

Abstract Introduction : Plasma glial fibrillary acidic protein (GFAP) may be associated with amyloid burden, neurodegeneration, and stroke but its specificity for Alzheimer's disease (AD) in the general population is unclear. We examined associations of plasma GFAP with amyloid and tau positron emission tomography (PET), cortical thickness, white matter hyperintensities (WMH), and cerebral microbleeds (CMBs). Methods : The study included 200 individuals from the Mayo Clinic Study of Aging who underwent amyloid and tau PET and magnetic resonance imaging and had plasma GFAP concurrently assayed; multiple linear regression and hurdle model analyses were used to investigate associations controlling for age and sex. Results : GFAP was associated with amyloid and tau PET in multivariable models. After adjusting for amyloid, the association with tau PET was no longer significant. GFAP was associated with cortical thickness, WMH, and lobar CMBs only among those who were amyloid‐positive. Discussion : This cross‐sectional analysis demonstrates the utility of GFAP as a plasma biomarker for AD‐related pathologies.
85-Year-Old Postsurgical Complex Patient Successfully Managed Remotely at the Novel Mayo Clinic’s Hospital at Home
Paulson, Margaret R. , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Maita, Karla C. , Garcia, John P. , Eldaly, Abdullah S. , Serrano, Luiza Palmieri , Forte, Antonio J. , Thompson, Jonathan C. , Maniaci, Michael J. , Maita, Karla , Eldaly, Abdullah , Palmieri-Serrano, Luiza , Forte, Antonio Jorge , Torres, Ricardo A , Maniaci, Michael J , Avila, Francisco R , Garcia, John P , Paulson, Margaret R

Mayo Clinic

Case Reports in Vascular Medicine | February 25, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-5

10.1155/2022/1439435 | PMID 35251735 Get It

An 85-year-old male presented to the podiatry clinic following a 1st to 5th left toe amputation as a complication of severe peripheral arterial disease and nonhealing wound despite endovascular intervention with an angiogram. At the visit, cellulitis with gangrene of the surgical site was noted. The patient was admitted to the brick and mortar (BAM) hospital and taken to surgery for a transmetatarsal amputation of the left limb. In the immediate postoperative period, the incisional margins appeared dusky creating concern for flap viability. The medical team recommended a vascular bypass versus a below-knee amputation. However, given the age, comorbidities, and nutritional status, the family refused further surgical intervention. As such, Mayo Clinic’s home hospital program, Advanced Care at Home (ACH), was consulted for continued nonsurgical acute management at home. The patient was transferred to ACH and transported home three days after BAM admission to continue IV antibiotic therapy and wound care. Discharge from ACH occurred 11 days after admission to the BAM hospital. This case highlights the importance of developing health care alternatives to traditional hospitalization and demonstrates that ACH can manage highly complex, elder postoperative patients from the comfort of their homes.
Exploring cryo-electron microscopy with molecular dynamics
Vant, John , Sarkar, Daipayan , Nguyen, Jonathan , Baker, Alexander T. , Vermaas, Josh V. , Singharoy, Abhishek , Vant, John W , Vermaas, Josh , Singharoy, Abhishek , Baker, Alexander , Sarkar, Daipayan , Nguyen, Jonathan

Mayo Clinic

Biochemical Society Transactions | February 25, 2022 | Volume: 50 | Issue: 1 | Pages: 569-581

10.1042/bst20210485 | PMID 35212361 Get It

Single particle analysis cryo-electron microscopy (EM) and molecular dynamics (MD) have been complimentary methods since cryo-EM was first applied to the field of structural biology. The relationship started by biasing structural models to fit low-resolution cryo-EM maps of large macromolecular complexes not amenable to crystallization. The connection between cryo-EM and MD evolved as cryo-EM maps improved in resolution, allowing advanced sampling algorithms to simultaneously refine backbone and sidechains. Moving beyond a single static snapshot, modern inferencing approaches integrate cryo-EM and MD to generate structural ensembles from cryo-EM map data or directly from the particle images themselves. We summarize the recent history of MD innovations in the area of cryo-EM modeling. The merits for the myriad of MD based cryo-EM modeling methods are discussed, as well as, the discoveries that were made possible by the integration of molecular modeling with cryo-EM. Lastly, current challenges and potential opportunities are reviewed.